FDA restricts access to Avandia, cites increased cardiovascular risks
October 15th 2010FDA has determined to significantly restrict the use of formulations that contain rosiglitazone (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline) to patients with Type 2 diabetes who cannot control their diabetes with other medications.
Women in healthcare get a website of their own
October 15th 2010The need to find balance in her own life led Anna Garrett, PharmD, to establish the National Association for Women in Health Care, an organization committed to helping nurses, pharmacists, and other women healthcare professionals take care of themselves.
History of diabetes treatment chronicled in New York Historical Society exhibition
October 15th 2010Recalling the desperate fight for life that was waged by juvenile diabetes patients not even a century ago, "Breakthrough: The Dramatic Story of the Discovery of Insulin" will be on view at the New York Historical Society from October 2010 through January 2011.
DEA leads first nationwide prescription drug "Take-Back" day
September 21st 2010The Drug Enforcement Administration (DEA), working with government, community, public health, and law enforcement partners, will hold a prescription drug "Take-Back" initiative that seeks to prevent increased pill abuse and theft.
National board launches online database of certified medical interpreters
September 21st 2010The National Board of Certification for Medical Interpreters has launched the National Registry of Certified Medical Interpreters, which serves as a central online resource to verify the credentials of Certified Medical Interpreters.
NACDS Pharmacy & Technology Conference honors industry leaders
September 21st 2010Many awards were presented at the National Association of Chain Drug Stores (NACDS) Pharmacy & Technology Conference, but the Association?s highest honor, the Harold W. Pratt Award, was bestowed upon industry leader Joe Conda, senior vice president of strategic planning at H.D. Smith.
NACDS 2010-2011 Chain Pharmacy Industry Profile illustrates pharmacy value
September 21st 2010The 13th edition of the National Association of Chain Drug Stores (NACDS) 2010-2011 Chain Pharmacy Industry Profile provides economic impact data, national and state-by-state information, and facts on retail and pharmacy trends.
NCPA to launch site for independent pharmacy buyers and sellers
September 21st 2010A new website being launched by the National Community Pharmacists Association (NCPA), www.PharmacyMatching.com, will bring together independent pharmacy owners preparing to sell their pharmacies, existing owners who desire additional stores, and entrepreneurs seeking to become pharmacy owners.
Ferring Pharmaceuticals joins race to fight prostate cancer
September 21st 2010Ferring Pharmaceuticals Inc. is in the race to end prostate cancer as an official sponsor of the Great Prostate Cancer Challenge/Dash for Dad, a series of races in the United States, led by ZERO ? The Project to End Prostate Cancer.
Kerr Drug launches comprehensive immunization program for flu season
September 21st 2010Kerr Drug, a community pharmacy that pioneered the training of clinical pharmacists to administer vaccines to patients, is launching an effort to meet the demand for flu shots. The company is beginning its flu shot campaign earlier than ever this year and providing vaccinations during operating hours at all its stores throughout North Carolina, with no appointments necessary.
Hospitalizations decline for peptic ulcer disease, H. pylori infection
September 21st 2010Hospitalization rates for peptic ulcer disease and Helicobacter pylori infection have decreased substantially since 1998, according to an analysis in the September issue of Emerging Infectious Diseases, HealthDay News reported.
CPOE warning system may reduce orders for inappropriate meds
September 21st 2010The implementation of a computerized provider order entry (CPOE) drug warning system can reduce orders for potentially inappropriate medications in hospitalized older patients, according to a study published in the Aug. 9 issue of the Archives of Internal Medicine, HealthDay News reported.
CDER speakers to address cardiovascular safety, diabetic drug development
September 21st 2010The Drug Information Association, in collaboration with FDA and the Cardiac Research Safety Consortium, will host Development of Type 2 Diabetes Mellitus Drugs Conference: State-of-the-Art Cardiovascular Safety Assessments, Oct. 5?6 in Washington, D.C.
Bisphosphonate exposure not linked to esophageal cancer
September 21st 2010There appears to be no association between the use of oral bisphosphonates and the risk of esophageal or gastric cancer, according to research published in the Aug. 11 issue of the Journal of the American Medical Association, HealthDay News reported.
FDA warns of aseptic meningitis risk with use of lamotrigine
September 21st 2010FDA issued a warning Aug. 12 that the drug lamotrigine (Lamictal, GlaxoSmithKline), approved to treat seizures and bipolar disorder, can cause aseptic meningitis, an inflammation not caused by bacterial infection of the protective membranes (meninges) that cover the brain and spinal cord.
Associations in favor of CMS proposed rule revising Medicaid pharmacy reimbursement formula
September 21st 2010Both the National Association of Chain Drug Stores and National Community Pharmacists Association favor the proposed rule by the Centers for Medicare & Medicaid Services (CMS) that would withdraw existing provisions of the Medicaid pharmacy reimbursement formula under the average manufacturer price (AMP) model.
FDA continues scrutiny of DTC genetic tests
September 15th 2010Underlying a recent FDA-hosted public meeting and workshop was the question of how FDA as a regulatory agency should increase its current oversight of clinical laboratories, specifically those developing genetic tests that may be offered at their own facilities or made available through direct-to-consumer channels.
Monitoring controlled substances
September 15th 2010Thirty-nine states now have a tool to help pharmacists identify at least some questionable prescriptions and suggest when a patient may be doctor-shopping or pharmacy-shopping in order to obtain controlled substances. That tool is the state prescription monitoring program.